| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Oct 29, 2025 | Neumora Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +1,915,700 | 6.00% | ✗ | $5M |
| Aug 1, 2025 | Aug 1, 2025 | Prime Medicine, Inc. | 10% Owner | Buy | 100.0 | +3,030,300 | 19.61% | ✗ | $10M |
| Apr 2, 2024 | Apr 4, 2024 | Boundless Bio, Inc. | 10% Owner | Buy | 100.0 | +200,000 | 12.01% | ✗ | $3.2M |
| Feb 15, 2024 | Feb 20, 2024 | Prime Medicine, Inc. | 10% Owner | Buy | 100.0 | +3,200,000 | 26.11% | ✗ | $20M |
| Feb 8, 2024 | Feb 12, 2024 | Sana Biotechnology, Inc. | 10% Owner | Buy | 96.3 | +1,818,181 | 5.39% | ✗ | $10M |
| Sep 19, 2023 | Sep 20, 2023 | Neumora Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,500,000 | 70.62% | ✗ | $25.5M |
| Sep 19, 2023 | Sep 20, 2023 | Neumora Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,500,000 | 70.62% | ✗ | $25.5M |
| Oct 24, 2022 | Oct 26, 2022 | Prime Medicine, Inc. | 10% Owner | Buy | 97.5 | +800,000 | 6.98% | ✗ | $13.6M |